Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 22578148)

1.

The impact of blood coagulability on atherosclerosis and cardiovascular disease.

Loeffen R, Spronk HM, ten Cate H.

J Thromb Haemost. 2012 Jul;10(7):1207-16. doi: 10.1111/j.1538-7836.2012.04782.x. Review.

PMID:
22578148
2.

Is thrombin a key player in the 'coagulation-atherogenesis' maze?

Borissoff JI, Spronk HM, Heeneman S, ten Cate H.

Cardiovasc Res. 2009 Jun 1;82(3):392-403. doi: 10.1093/cvr/cvp066. Epub 2009 Feb 19. Review.

3.

Tissue factor-driven thrombin generation and inflammation in atherosclerosis.

ten Cate H.

Thromb Res. 2012 May;129 Suppl 2:S38-40. doi: 10.1016/j.thromres.2012.02.028. Epub 2012 Mar 6. Review.

PMID:
22398011
4.

Thrombin generation and atherosclerosis.

Kalz J, ten Cate H, Spronk HM.

J Thromb Thrombolysis. 2014 Jan;37(1):45-55. doi: 10.1007/s11239-013-1026-5. Review.

PMID:
24241912
5.

Thrombin and protease-activated receptors (PARs) in atherothrombosis.

Martorell L, Martínez-González J, Rodríguez C, Gentile M, Calvayrac O, Badimon L.

Thromb Haemost. 2008 Feb;99(2):305-15. doi: 10.1160/TH07-08-0481. Review.

PMID:
18278179
6.

Overview of the postulated mechanisms linking cancer and thrombosis.

ten Cate H, Falanga A.

Pathophysiol Haemost Thromb. 2008;36(3-4):122-30. doi: 10.1159/000175150. Epub 2009 Jan 27. Review.

PMID:
19176985
8.

Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.

Seehaus S, Shahzad K, Kashif M, Vinnikov IA, Schiller M, Wang H, Madhusudhan T, Eckstein V, Bierhaus A, Bea F, Blessing E, Weiler H, Frommhold D, Nawroth PP, Isermann B.

Circulation. 2009 Sep 1;120(9):774-84. doi: 10.1161/CIRCULATIONAHA.109.849539. Epub 2009 Aug 17.

9.

[Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].

Sertić J, Skorić B, Lovrić J, Bozina T, Reiner Z.

Acta Med Croatica. 2010 Oct;64(4):237-45. Review. Croatian.

PMID:
21688606
10.

Early atherosclerosis exhibits an enhanced procoagulant state.

Borissoff JI, Heeneman S, Kilinç E, Kassák P, Van Oerle R, Winckers K, Govers-Riemslag JW, Hamulyák K, Hackeng TM, Daemen MJ, ten Cate H, Spronk HM.

Circulation. 2010 Aug 24;122(8):821-30. doi: 10.1161/CIRCULATIONAHA.109.907121. Epub 2010 Aug 9.

11.

The Northwick Park Heart Study: evidence from the laboratory.

Ten Cate H, Meade T.

J Thromb Haemost. 2014 May;12(5):587-92. doi: 10.1111/jth.12545. Review.

PMID:
24593861
12.

Role of thrombogenic factors in the development of atherosclerosis.

Marutsuka K, Hatakeyama K, Yamashita A, Asada Y.

J Atheroscler Thromb. 2005;12(1):1-8. Review.

13.
14.

Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease.

Husmann M, Barton M.

Expert Opin Investig Drugs. 2007 May;16(5):563-7. Review.

PMID:
17461731
15.

The role of coagulation in chronic inflammatory disorders: a jack of all trades.

Borensztajn KS, von der Thüsen JH, Spek CA.

Curr Pharm Des. 2011;17(1):9-16. Review.

PMID:
21222644
16.

Blood coagulation and the risk of atherothrombosis: a complex relationship.

Spronk HM, van der Voort D, Ten Cate H.

Thromb J. 2004 Dec 1;2(1):12.

17.

Intertwining of thrombosis and inflammation in atherosclerosis.

Croce K, Libby P.

Curr Opin Hematol. 2007 Jan;14(1):55-61. Review.

PMID:
17133101
18.

Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.

Pawlinski R, Mackman N.

Crit Care Med. 2004 May;32(5 Suppl):S293-7. Review.

PMID:
15118533
19.

The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?

Cimmino G, D'Amico C, Vaccaro V, D'Anna M, Golino P.

Expert Rev Cardiovasc Ther. 2011 Apr;9(4):517-23. doi: 10.1586/erc.11.40. Review.

PMID:
21517734
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk